187 related articles for article (PubMed ID: 29936043)
1. Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis.
Vilahur G; Casaní L; Peña E; Crespo J; Juan-Babot O; Ben-Aicha S; Mendieta G; Béjar MT; Borrell M; Badimon L
Int J Cardiol; 2018 Nov; 270():28-35. PubMed ID: 29936043
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride-induced cardiac lipotoxicity is mitigated by Silybum marianum.
Vilahur G; Sutelman P; Mendieta G; Ben-Aicha S; Borrell-Pages M; Peña E; Crespo J; Casaní L; Badimon L
Atherosclerosis; 2021 May; 324():91-101. PubMed ID: 33857761
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
4. Reply to the letter by Dr. Ulas to the manuscript entitled: "Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis".
Vilahur G; Casaní L; Peña E; Crespo J; Juan-Babot O; Ben-Aicha S; Mendieta G; Béjar MT; Borrell-Pagès M; Badimon L
Int J Cardiol; 2018 Nov; 270():78. PubMed ID: 30031622
[No Abstract] [Full Text] [Related]
5. Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.
DeNicola M; Du J; Wang Z; Yano N; Zhang L; Wang Y; Qin G; Zhuang S; Zhao TC
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E630-43. PubMed ID: 25117407
[TBL] [Abstract][Full Text] [Related]
6. TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in Pigs.
Malka A; Meerkin D; Barac YD; Malits E; Bachner-Hinenzon N; Carasso S; Ertracht O; Angel I; Shofti R; Youdim M; Abassi Z; Binah O
J Cardiovasc Pharmacol; 2015 Aug; 66(2):214-22. PubMed ID: 25900266
[TBL] [Abstract][Full Text] [Related]
7. Spondias mombin L. attenuates ventricular remodelling after myocardial infarction associated with oxidative stress and inflammatory modulation.
Pereira BLB; Rodrigue A; Arruda FCO; Bachiega TF; Lourenço MAM; Correa CR; Azevedo PS; Polegato BF; Okoshi K; Fernandes AAH; de Paiva SAR; Zornoff LAM; Power KA; Minicucci MF
J Cell Mol Med; 2020 Jul; 24(14):7862-7872. PubMed ID: 32468694
[TBL] [Abstract][Full Text] [Related]
8. Comment on "Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis".
Ulas T
Int J Cardiol; 2018 Nov; 270():81. PubMed ID: 30220380
[No Abstract] [Full Text] [Related]
9. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
[TBL] [Abstract][Full Text] [Related]
10. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model.
Vilahur G; Casani L; Peña E; Juan-Babot O; Mendieta G; Crespo J; Badimon L
Int J Cardiol; 2014 Aug; 175(3):528-38. PubMed ID: 25023790
[TBL] [Abstract][Full Text] [Related]
13. Melatonin prevents adverse myocardial infarction remodeling via Notch1/Mfn2 pathway.
Pei H; Du J; Song X; He L; Zhang Y; Li X; Qiu C; Zhang Y; Hou J; Feng J; Gao E; Li D; Yang Y
Free Radic Biol Med; 2016 Aug; 97():408-417. PubMed ID: 27387769
[TBL] [Abstract][Full Text] [Related]
14. Postinfarction exercise training alleviates cardiac dysfunction and adverse remodeling via mitochondrial biogenesis and SIRT1/PGC-1α/PI3K/Akt signaling.
Jia D; Hou L; Lv Y; Xi L; Tian Z
J Cell Physiol; 2019 Dec; 234(12):23705-23718. PubMed ID: 31187505
[TBL] [Abstract][Full Text] [Related]
15. Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats.
Murino Rafacho BP; Portugal Dos Santos P; Gonçalves AF; Fernandes AAH; Okoshi K; Chiuso-Minicucci F; Azevedo PS; Mamede Zornoff LA; Minicucci MF; Wang XD; Rupp de Paiva SA
PLoS One; 2017; 12(5):e0177521. PubMed ID: 28494028
[TBL] [Abstract][Full Text] [Related]
16. 5-Methoxytryptophan attenuates postinfarct cardiac injury by controlling oxidative stress and immune activation.
Hsu WT; Tseng YH; Jui HY; Kuo CC; Wu KK; Lee CM
J Mol Cell Cardiol; 2021 Sep; 158():101-114. PubMed ID: 34087195
[TBL] [Abstract][Full Text] [Related]
17. Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.
Rathinavel A; Sankar J; Mohammed Sadullah SS; Niranjali Devaraj S
Fundam Clin Pharmacol; 2018 Feb; 32(1):51-59. PubMed ID: 29059499
[TBL] [Abstract][Full Text] [Related]
18. Integration of "omics" techniques: Dronedarone affects cardiac remodeling in the infarction border zone.
Chilukoti RK; Lendeckel J; Darm K; Bukowska A; Goette A; Sühling M; Utpatel K; Peters B; Homuth G; Völker U; Wolke C; Scharf C; Lendeckel U
Exp Biol Med (Maywood); 2018 Jul; 243(11):895-910. PubMed ID: 30105952
[TBL] [Abstract][Full Text] [Related]
19. Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction.
Burstein B; Maguy A; Clément R; Gosselin H; Poulin F; Ethier N; Tardif JC; Hébert TE; Calderone A; Nattel S
J Pharmacol Exp Ther; 2007 Dec; 323(3):916-23. PubMed ID: 17875610
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling.
Eid RA; Alkhateeb MA; Eleawa S; Al-Hashem FH; Al-Shraim M; El-Kott AF; Zaki MSA; Dallak MA; Aldera H
Basic Res Cardiol; 2018 Feb; 113(2):13. PubMed ID: 29392420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
